MorphicLogo.jpg
Morphic Announces Participation in Upcoming Investor Conferences
03 sept. 2020 16h30 HE | Morphic Therapeutic
WALTHAM, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious...